BACKGROUND: Studies suggest that peanut allergy prevalence might be increasing, but these results have not yet been substantiated. OBJECTIVE: We conducted a follow-up study to determine whether peanut allergy prevalence in Montreal is increasing. METHODS: Questionnaires regarding peanut ingestion were administered to parents of children in randomly selected kindergarten through grade 3 classrooms between December 2000 and September 2002 and between October 2005 and December 2007. Respondents were stratified as (1) peanut tolerant, (2) never/rarely ingest peanut, (3) convincing history of peanut allergy, or (4) uncertain history of peanut allergy. Children in group 3 with positive skin prick test responses were considered to have peanut allergy. Children in groups 2 and 4 with positive skin prick test responses had peanut-specific IgE levels measured, and if the value was less than 15 kU/L, an oral peanut challenge was performed. Multiple imputation was used to generate prevalence estimates that incorporated respondents providing incomplete data and nonrespondents. RESULTS: Of 8,039 children surveyed in 2005-2007, 64.2% of parents responded. Among those providing complete data, the prevalence was 1.63% (95% CI, 1.30% to 2.02%) in 2005-2007 versus 1.50% (95% CI, 1.16% to 1.92%) in 2000-2002. After adjustment for missing data, the prevalence was 1.62% (95% credible interval, 1.31% to 1.98%) versus 1.34% (95% credible interval, 1.08% to 1.64%), respectively. The differences between the prevalences in 2005-2007 and 2000-2002 were 0.13% (95% credible interval, -0.38% to 0.63%) among those providing complete data and 0.28% (95% credible interval, -0.15% to 0.70%) after adjustment for missing data. CONCLUSIONS: This is the first North American study to document temporal trends in peanut allergy prevalence by corroborating history with confirmatory tests. The results suggest a stable prevalence, but wide CIs preclude definitive conclusions.
BACKGROUND: Studies suggest that peanutallergy prevalence might be increasing, but these results have not yet been substantiated. OBJECTIVE: We conducted a follow-up study to determine whether peanutallergy prevalence in Montreal is increasing. METHODS: Questionnaires regarding peanut ingestion were administered to parents of children in randomly selected kindergarten through grade 3 classrooms between December 2000 and September 2002 and between October 2005 and December 2007. Respondents were stratified as (1) peanut tolerant, (2) never/rarely ingest peanut, (3) convincing history of peanutallergy, or (4) uncertain history of peanutallergy. Children in group 3 with positive skin prick test responses were considered to have peanutallergy. Children in groups 2 and 4 with positive skin prick test responses had peanut-specific IgE levels measured, and if the value was less than 15 kU/L, an oral peanut challenge was performed. Multiple imputation was used to generate prevalence estimates that incorporated respondents providing incomplete data and nonrespondents. RESULTS: Of 8,039 children surveyed in 2005-2007, 64.2% of parents responded. Among those providing complete data, the prevalence was 1.63% (95% CI, 1.30% to 2.02%) in 2005-2007 versus 1.50% (95% CI, 1.16% to 1.92%) in 2000-2002. After adjustment for missing data, the prevalence was 1.62% (95% credible interval, 1.31% to 1.98%) versus 1.34% (95% credible interval, 1.08% to 1.64%), respectively. The differences between the prevalences in 2005-2007 and 2000-2002 were 0.13% (95% credible interval, -0.38% to 0.63%) among those providing complete data and 0.28% (95% credible interval, -0.15% to 0.70%) after adjustment for missing data. CONCLUSIONS: This is the first North American study to document temporal trends in peanutallergy prevalence by corroborating history with confirmatory tests. The results suggest a stable prevalence, but wide CIs preclude definitive conclusions.
Authors: Julie Barnett; Kate Muncer; Jo Leftwich; Richard Shepherd; Monique M Raats; M Hazel Gowland; Kate Grimshaw; Jane S Lucas Journal: BMC Public Health Date: 2011-09-26 Impact factor: 3.295
Authors: Ananth Thyagarajan; Pooja Varshney; Stacie M Jones; Scott Sicherer; Robert Wood; Brian P Vickery; Hugh Sampson; A Wesley Burks Journal: J Allergy Clin Immunol Date: 2010-07 Impact factor: 10.793
Authors: A Thyagarajan; S M Jones; A Calatroni; L Pons; M Kulis; C S Woo; M Kamalakannan; B P Vickery; A M Scurlock; A Wesley Burks; W G Shreffler Journal: Clin Exp Allergy Date: 2012-08 Impact factor: 5.018
Authors: Stephen C Dreskin; Mark T Tripputi; Michael T Aubrey; S Shahzad Mustafa; Dan Atkins; Harvey L Leo; Benjamin Song; Darcy Schlichting; Hanna Talwar; Qian Wang; Brian M Freed Journal: Clin Immunol Date: 2010-09-17 Impact factor: 3.969
Authors: Larisa C Lotoski; F Estelle R Simons; Rishma Chooniedass; Joel Liem; Isha Ostopowich; Allan B Becker; Kent T HayGlass Journal: PLoS One Date: 2010-06-17 Impact factor: 3.240
Authors: Corinne A Keet; Jessica H Savage; Shannon Seopaul; Roger D Peng; Robert A Wood; Elizabeth C Matsui Journal: Ann Allergy Asthma Immunol Date: 2014-01-07 Impact factor: 6.347